AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04351789 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention
Description: The written and verbal information provided at discharge to patients in the intervention arm will consist of:~An explanation of the normal recovery period after hospitalization due to COVID-19. What can the patient expect physically, psychologically and emotionally, and what coping mechanism might be appropriate Social support in the recovery period and how this can be used constructively. In case of worsening of symptoms - physically or psychologically, where can the patient get help after discharge from hospital.~These points are based on crisis psychology, enhancing the patients empowerment and self-management after discharge from hospital.
Study NCT01876004 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: 50 mg/m2, IM (intramuscularly), single dose
Study NCT01876004 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Prescribed Placebo IM (intramuscularly), single dose
Study NCT03233984 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: sensibilisation program Ma maison, mon environnement santé
Description: The aim of this program is to spread the awarness about endocrine disruptors through workshops and presentation.
Study NCT03233984 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: sensibilisation program Ma maison, mon environnement santé
Description: The aim of this program is to spread the awarness about endocrine disruptors through workshops and presentation.
Study NCT03338738 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Stool culture ans swab
Description: Patients with ESBL enterobacteria, antibiotic pressure are patients with ESBL positive result diagnosed by stool culture and a rectal swab.~The intervention correspond to addition of 4 stool samples (or 4 rectal swabs in the absence of stool emission) and a blood sample.
Study NCT03463642 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: vitamin D3
Description: 100,000IU
Study NCT03463642 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Pill
Description: Dicalcium phosphate, microcrystalline cellulose, silicium dioxide, magnesium stearate
Study NCT03463642 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Pill
Description: Dicalcium phosphate, microcrystalline cellulose, silicium dioxide, magnesium stearate
Study NCT03463642 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: orange syrup
Description: 100 drops orange syrup
Study NCT03463642 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: orange syrup
Description: 100 drops orange syrup
Study NCT03463642 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mineral oil
Description: Paraffinum Liquidum,Isopropyl Palmitate,Parfum
Study NCT03463642 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: mineral oil
Description: Paraffinum Liquidum,Isopropyl Palmitate,Parfum
Study NCT03463642 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Penetrator
Description: Tangerine essential oil (10ml)
Study NCT04496570 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: periodontal therapy
Description: Non surgical periodontal therapy was performed to patients with peridontitis
Study NCT02231099 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Prolift + M
Description: prolapse surgery with mesh
Study NCT02231099 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: conventional vaginal prolapse surgery
Description: conventional vaginal prolapse surgery;anterior colporrhaphy, posterior colporrhaphy
Study NCT03405961 — intervention group
Intervention type: DEVICE
Intervention: Carestream 3600 intra oral scan
Description: Carestream 3600 is CE marked intra oral scanner manufactured by Carestream Dental. It is already licensed for use in dentistry to produce digital study models. The scanner is 220 x 38 x 58 mm large and operates using video capture technology. It emits no radiation.~Carestream 3600 is connected to a computer via a USB port and a computer software (CS Model +) converts the scan into digital study models using trigonometric calculations. The software is then used to take measurements on the digital models and calculate PAR scores
Study NCT02820948 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin E ointment application
Description: Before the skin stapling and after the subcutaneous irrigation with normal saline, sterile Vitamin E acetate ointment was applied in the subcutaneous tissue; 2 ml were applied in the suprapubic incision and 0.5 ml in the rest of port sites.
Study NCT02460601 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Qizhiweitong granule
Study NCT02460601 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Qizhiweitong granule
Study NCT03337490 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivermectin 0.5% Topical Application Lotion
Description: Subjects on Test Product will receive a single dose, 117g, during the study to be applied at baseline.
Study NCT03337490 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ivermectin 0.5% Topical Application Lotion [SKLICE]
Description: Subjects on Reference Product will receive a single dose, 117g, during the study to be applied at baseline.
Study NCT03337490 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo 0% Lotion
Description: Subjects on Placebo will receive a single dose, 117g, during the study to be applied at baseline.
Study NCT04095429 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expect Respect
Description: Expect Respect is a 24 session curriculum designed to support middle school students to increase skills in emotion regulation, relationship skills, communication, and positive bystander intervention behaviors.
Study NCT04095429 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Usual Care
Description: Participants will be connected via a warm referral to available individual behavioral health supports and resources in their community that can support them.
Study NCT02292069 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine besylate/Atorvastatin calcium
Description: Amlodipine besylate/Atorvastatin calcium 10/80 mg
Study NCT02292069 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amlodipine besylate/Atorvastatin calcium
Description: Amlodipine besylate/Atorvastatin calcium 10/80 mg
Study NCT00973713 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RAD001
Description: 10mg/d
Study NCT01689194 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: genexolPM + cisplatin
Study NCT02859584 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Measure OF SERUM TOTAL CORTISOL, SERUM FREE AND SALIVARY CORTISOL
Study NCT00837317 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Olive Oil, SF, SF+DMP, SF+phenols
Description: All the volunteer subjects will be administered four breakfast meals that have been prepared with four different types of oil, each of which will have been subjected to a standardised frying. The meals will be administered according to a cross-randomized Latin squares design
Study NCT03502551 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine
Description: Ketamine infusion (0.5 mg/kg) over 40 minutes.
Study NCT04004871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel, Cisplatin and Fluorouracil
Description: Patients receive Nab-paclitaxel (200mg/m2 on day 1), cisplatin (60mg/m2 on day 1) and fluorouracil (600mg/m2 on Days 1 to 5) every three weeks for three cycles before concurrent chemoradiotherapy.
Study NCT04004871 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: concurrent chemoradiotherapy
Description: Patients receive radical radiotherapy and cisplatin (100mg/m2) every three weeks for three cycles during radiotherapy.
Study NCT01745497 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ferrous sulfate
Description: 3mg/kg liquid
Study NCT01745497 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Equivalent volume of liquid with similar color and taste.
Study NCT03033550 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: brief negotiated mobile application
Description: The intervention will supplement the standard of care with the following steps: (1) mobile- based brief negotiated Intervention ( BNI); (2) a customized companion communication vaccine report to be given before AFG sees provider; and (3) automated interactive Electronic Recall/Reminder Messages (Text messaging), including text messaging and access to a website which includes information about HPV, HPV Vaccine, and cervical cancer screening guideline.
Study NCT02546700 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lebrikizumab
Description: Lebrikizumab 125 milligrams (mg) will be administered subcutaneously once in every 4 weeks.
Study NCT02546700 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo will be administered subcutaneously once in every 4 weeks.
Study NCT03238170 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRI scan
Description: MRI scan using the Siemens Aera® (Siemens AG Healthcare, Erlangen, Germany) on the same day as their treatment planning CT scan
Study NCT04036370 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PECS group
Description: Pecs block performed using ultrasound guidance. Standard pain follow up and monitorization will be performed.
Study NCT04036370 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control group
Description: Standard pain follow up and monitorization will be performed.
Study NCT01828151 — intervention group
Intervention type: DEVICE
Intervention: Noninvasive ventilation mask
Study NCT02470988 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Behavioural Analysis System of Psychotherapy
Study NCT02470988 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBASP Without DPI
Study NCT03405233 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Double vein cuffed ePTFE graft both at the inflow and outflow ends
Description: Vein cuff is obtained from a segment of one of the arm veins (cephalic or basilica) after incising it longitudinally and wrapped around both ends of PTFE Graft
Study NCT03405233 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: single vein cuffed eTFE graft both at the inflow and outflow ends
Description: Vein cuff is obtained from a segment of one of the arm veins (cephalic or basilica) after incising it longitudinally and wrapped around the venous end of PTFE Graft
Study NCT03405233 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ePTFE graft without any cuff
Description: anastmosis between arterial and venous side usinf non cuffed ePTFE graft
Study NCT01787162 — intervention group
Intervention type: OTHER
Intervention: Echocardiography, spiroergometry, cardiac catheterization
Description: patients with CMPD will undergo echocardiography, spiroergometry, and right heart catheterization, if indicated
Study NCT02152280 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Danhong Injection
Description: Danhong Injection 40 ml add 250 ml of 0.9% sodium chloride solution, injection intravenous drip, 1 time a day, for 10 days.
Study NCT02152280 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: 0.9% sodium chloride solution 40 ml add 250 ml of 0.9% sodium chloride solution, injection intravenous drip, 1 time a day, for 10 days;
Study NCT02619162 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nintedanib
Description: Tablets of 100 mg. or 150 mg.
Study NCT02619162 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole
Description: Tablet of 2.5 mg.
Study NCT03005405 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ionomer Restoration (control)
Description: Restoration of moderate caries lesions after partial caries removal using high viscosity glass ionomer cements
Study NCT03005405 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ionomer Sealant (test)
Description: Sealing of moderate caries lesions without any caries removal or cavity opening.
Study NCT03005405 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Oral hygiene orientation and professional fluoride application
Description: Oral hygiene orientation and professional fluoride application
Study NCT03005405 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Oral hygiene orientation and professional fluoride application
Description: Oral hygiene orientation and professional fluoride application
Study NCT01782391 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stimulation
Study NCT01782391 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: SHAM
Description: no stimulation
Study NCT01406613 — intervention group
Intervention type: OTHER
Intervention: Observation
Description: In this study we will examine the changes in bone density by DXA and QUS and bone turnover after stopping Bisphosphonate treatment. As we wish to measure the speed of offset of effects of treatment we have scheduled visits at 24 week intervals in order to fully assess this effect.
Study NCT03637439 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided Percutaneous Neuromodulation
Description: It's a new intervention of sport physiotherapy. It´s an invasive technique. It is necessary an ultrasound
Study NCT03637439 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Ultrasound-guided Percutaneous Needle
Description: Same protocol without electricity
Study NCT02004678 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: DS-1150b
Study NCT02004678 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Placebo
Study NCT03152929 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paravertebral Block
Description: 20-30 mL 0.5% Ropivacaine
Study NCT03152929 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pectoral Nerve Block
Description: 20-30 mL 0.5% Ropivacaine
Study NCT02801812 — intervention group
Intervention type: DEVICE
Intervention: nailfold capillaroscopy
Description: Detection by nailfold capillaroscopy of capillary abnormalities in patients with Systemic Lupus Erythematosus and comparison with healthy controls at enrolment
Study NCT03509519 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: NMES-Millicurrent
Description: Stimulating electrodes will be applied to the quadriceps muscle of each leg 3 times a week for 4 weeks (12 sessions) for 40min per leg.
Study NCT03509519 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NMES-Millicurrent
Description: Stimulating electrodes will be applied to the quadriceps muscle of each leg 3 times a week for 4 weeks (12 sessions) for 40min per leg.
Study NCT04421690 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Training
Description: Participants (n=15) will complete computerized cognitive training games and activities online 3 times/week for 8 weeks.
Study NCT04218851 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Posaconazole IV
Description: Posaconazole (POS) 6 mg/kg body weight by IV infusion
Study NCT04218851 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Posaconazole PFS
Description: Dosing based on weight-band taken orally
Study NCT01018810 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2525623 Intravenous
Description: administered intravenously at randomization and every 2 weeks for 6 weeks
Study NCT01018810 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2525623 Subcutaneous
Description: administered subcutaneously at randomization and every 2 weeks for 6 weeks
Study NCT01018810 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Intravenous
Description: administered intravenously at randomization and every 2 weeks for 6 weeks
Study NCT01018810 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Subcutaneous
Description: administered subcutaneously at randomization and every 2 weeks for 6 weeks
Study NCT02069860 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bone Anchored Port System (BAP)
Description: The port body will be implanted onto the petrous bone and a sealing cap, a twofold valve system and a catheter are connected to the port body. The catheter is tunneled under the skin, enters the internal jugular vein and ends in the right atrium of the heart. The novelty of the access lies in its location (retro auricular on petrous bone) and its bone fixation.
Study NCT03490812 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PET scan
Description: Investigational PET scan as add-on to standard-of-care scan
Study NCT03490812 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Retrospective data analysis
Description: Review of pre-existing data from January 1, 2001 through December 5, 2017
Study NCT04091607 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Music Therapy
Description: Subject will listen to Music using provided ear buds or headphones.
Study NCT02529228 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Meal (Eating) Frequency
Description: Dividing meal intake into 2 or 6 meals with equal energy content
Study NCT02529228 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Protein Composition
Description: Consuming meals with higher or lower protein.
Study NCT01838980 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Motus GI Clean-Up Device
Study NCT02471326 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VRC-HIVMAB060-00-AB (VRC01)
Description: A potent HIV-specific monoclonal antibody
Study NCT03300596 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief intervention to prevent suicide attempt
Description: A patient-centered, 3-session intervention that calls for videotaping the narrative story of a patient's suicide attempt, in his/her own words (session 1); reviewing segments of the tape to arrive at a shared understanding of the attempt and the sequence of events that led to it (session 2); and using this information, along with a homework task completed by the patient in-between sessions, in order to develop a collaborative, comprehensive written safety plan that addresses the patient's unique vulnerabilities (session 3).
Study NCT03300596 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Enhanced treatment as usual
Description: Safety procedures' control intervention. For these procedures we will share summary results of the research assessments regarding suicidal thoughts, suicidal behaviors, alcohol and drug use and related problems, and depressive symptoms with appropriate hospital clinical staff. We will also arrange to send this information, with participants' permission, to their ongoing therapist or treatment program and, if none exists, to the therapist or program to which they are being referred. In this regard, the research assessment protocol serves a dual function of helping with additional monitoring of high-risk patients in addition to providing data for the study.
Study NCT01864005 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Description: 90mg tablets. loading dose of 180mg ticagrelor tablets (two 90mg tablets) taken orally, followed by 90mg of ticagrelor 12 hours after the first dose. Duration of treatment: 6 weeks.
Study NCT01864005 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clopidogrel
Description: 75mg capsule. loading dose of 600mg clopidogrel capsules (eight 75mg capsules) taken orally, follow by 75mg of clopidogrel capsules orally od. Duration of treatment: 6 weeks.
Study NCT03764293 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-1210
Description: Subjects receive SHR-1210 intravenously, Dosage form: lyophilised powder, Strength: 200 mg /vial
Study NCT03764293 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apatinib
Description: Subjects receive Apatinib orally, Dosage form: tablet, Strength: 250 mg/tablet
Study NCT03764293 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sorafenib
Description: Subjects receive Sorafenib orally, Dosage form: tablet, Strength: 0.2 g/tablet
Study NCT04421690 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Trivia Training
Description: Participants (n=15) will receive computerized trivia questions to answer and submit 3 times/week for 8 weeks.
Study NCT03962985 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Guided tour at the Montreal Museum of Fine Arts
Description: * The duration of the participation -3 months~* The duration of the guided tour-45 minutes, each week~* All participants will be asked to fill out some specific online questionnaires during their participations in the study
Study NCT03682497 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD9977
Description: AZD9977 capsules taken orally for 28 days.
Study NCT03682497 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Spironolactone
Description: Spironolactone tablets taken orally for 28 days.
Study NCT04004598 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: golf training
Description: 12 weeks of training by Professional Golf Association professional